Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct 25;9(2):91-100.
doi: 10.1038/nrcardio.2011.159.

Mechanisms of disease: hypertrophic cardiomyopathy

Affiliations
Review

Mechanisms of disease: hypertrophic cardiomyopathy

Norbert Frey et al. Nat Rev Cardiol. .

Abstract

Hypertrophic cardiomyopathy (HCM) is the most-common monogenically inherited form of heart disease, characterized by thickening of the left ventricular wall, contractile dysfunction, and potentially fatal arrhythmias. HCM is also the most-common cause of sudden cardiac death in individuals younger than 35 years of age. Much progress has been made in the elucidation of the genetic basis of HCM, resulting in the identification of more than 900 individual mutations in over 20 genes. Interestingly, most of these genes encode sarcomeric proteins, such as myosin-7 (also known as cardiac muscle β-myosin heavy chain; MYH7), cardiac myosin-binding protein C (MYBPC3), and cardiac muscle troponin T (TNNT2). However, the molecular events that ultimately lead to the clinical phenotype of HCM are still unclear. We discuss several potential pathways, which include altered calcium cycling and sarcomeric calcium sensitivity, increased fibrosis, disturbed biomechanical stress sensing, and impaired cardiac energy homeostasis. An improved understanding of the pathological mechanisms involved will result in greater specificity and success of therapies for patients with HCM.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Am Coll Cardiol. 2003 May 21;41(10):1776-82 - PubMed
    1. Circulation. 2001 Jul 17;104(3):317-24 - PubMed
    1. Circulation. 2003 Sep 23;108(12):1455-60 - PubMed
    1. JAMA. 1996 Jul 17;276(3):199-204 - PubMed
    1. J Mol Cell Cardiol. 2011 Apr;50(4):613-20 - PubMed

MeSH terms

Substances